Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis
| العنوان: | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis |
|---|---|
| المؤلفون: | Jian Zhang, Anding Xu, Xin Wang, Kangning Chen, Dapeng Mo, Zhongrong Miao, Yuming Xu, Benyan Luo, Bin Peng, Yong Huo, Jizong Zhao, Wei Wang, Shuo Wang, Chen Wang, Linong Ji, Shizheng Wu, Yi Yang, Junbo Ge, Xunming Ji, Tong Zhang, Tielin Li, Ning Wang, Peng Xie, Yun Xu, Jinsheng Zeng, Chaodong Zhang, Zhuo Zhang, Gang Zhao, Yuhua Fan, Jian Yu, Hongbing Chen, Jiangang Duan, Wenhao Zhu, Fubing Ouyang, Yicong Chen, Linfang Lan, Li Guo, Li He, Xiaoyuan Niu, Dingfeng Su, Beisha Tang |
| المصدر: | Stroke and Vascular Neurology Stroke and Vascular Neurology, Vol 5, Iss 2 (2020) |
| بيانات النشر: | BMJ Publishing Group, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Pediatrics, medicine.medical_specialty, China, Consensus, brain, Clinical Decision-Making, MEDLINE, 030204 cardiovascular system & hematology, Guidelines, lcsh:RC346-429, Brain Ischemia, Decision Support Techniques, Time-to-Treatment, 03 medical and health sciences, Sinus Thrombosis, Intracranial, 0302 clinical medicine, vein, Predictive Value of Tests, Risk Factors, medicine, Humans, Cerebral venous sinus thrombosis, Vein, Stroke, lcsh:Neurology. Diseases of the nervous system, Evidence-Based Medicine, business.industry, Incidence (epidemiology), Warfarin, Guideline, Evidence-based medicine, medicine.disease, medicine.anatomical_structure, Treatment Outcome, Neurology, Neurology (clinical), Cardiology and Cardiovascular Medicine, business, 030217 neurology & neurosurgery, medicine.drug, MRI |
| الوصف: | AimCerebral venous sinus thrombosis (CVST) is a less common cerebrovascular disease that predominantly affects young patients. The incidence of CVST is 2–5/10 000 000/year, accounting for 0.5%–1% of all stroke. To reduce mortality and morbidity associated with CVST, Chinese Stroke Association commissioned the authors to write the current guideline on the management of CVST.MethodsPubMed (MEDLINE), CNKI and Wanfang database were searched for studies related to CVST from 1 January 1990 to 31 July 2019. Data were synthesised by evidence tables. Each recommendation was fully discussed by the writing group members and reviewed by Chinese Stroke Association Stroke Fellow Committees. Levels of evidence grading algorithm of Chinese Stroke Association was used to grade each recommendation.ResultsThis guideline mainly focuses on the diagnostic evaluation, therapeutic strategies and secondary prevention of CVST. CT/CTV and MRI/MRV are recommended in the initial imaging evaluation of patients with suspected CVST. Anticoagulation therapy with low-molecular weight heparin should be initiated in patients with CVST immediately. After the acute stage, warfarin is recommended for 3–6 months to prevent the recurrence of CVST and other venous thromboembolic events.ConclusionsThe guideline summarises the current evidence regarding the management of CVST, and provides references for diagnosis, treatment and secondary prevention of CVST in China. |
| اللغة: | English |
| تدمد: | 2059-8696 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56524a07c1ad3776e9eca374bfd64b08Test http://europepmc.org/articles/PMC7337369Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....56524a07c1ad3776e9eca374bfd64b08 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 20598696 |
|---|